The dark side of clinical trials and remedial strategies in india
UPI Journal of Pharmaceutical, Medical and Health Sciences · 2021
DOI: 10.37022/jpmhs.v3i2.21 ↗Kurz gefasst
Fachartikel in der Zeitschrift UPI Journal of Pharmaceutical, Medical and Health Sciences, 2021. Verfasst von Raja Sekhar Reddy Poonuru und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
India offers unique benefits to the clinical research fraternity of the world. Breadth of genetic variations, willing subjects due to poverty and abundant research talent brings the world to the door steps of our country. India needs to get its legal framework in to order to check the local exploitation and regulate unscrupulous foreign and domestic researchers. No law is effective unless it is implemented vigorously. Therefore strong executive institutions should be created to implement the laws with severe deterrent punishments. Pharmaceutical practitioners must take this to heart.
Zitieren
APA
Poonuru, R. S. R., Gabriela, K., Cheruku, R., Sreeramula, S., Mothukuri, P., Bandari, S., Bommineni, T. R., & Madupu, A. (2021). The dark side of clinical trials and remedial strategies in india. UPI Journal of Pharmaceutical, Medical and Health Sciences. https://doi.org/10.37022/jpmhs.v3i2.21
Vancouver
Poonuru RSR, Gabriela K, Cheruku R, Sreeramula S, Mothukuri P, Bandari S, et al. The dark side of clinical trials and remedial strategies in india. UPI Journal of Pharmaceutical, Medical and Health Sciences. 2021. doi:10.37022/jpmhs.v3i2.21
BibTeX
@article{Poonuru2021,
author = {Poonuru, Raja Sekhar Reddy and Gabriela, Keerthana and Cheruku, Rohini and Sreeramula, Swetha and Mothukuri, Prajwitha and Bandari, Sneha and Bommineni, Thanuj Reddy and Madupu, Akhila},
title = {The dark side of clinical trials and remedial strategies in india},
journal = {UPI Journal of Pharmaceutical, Medical and Health Sciences},
year = {2021},
doi = {10.37022/jpmhs.v3i2.21}
}
EUVIMED